Home » BioRelix Enters Antibacterial Collaboration With Merck
BioRelix Enters Antibacterial Collaboration With Merck
BioRelix, Inc. Monday announced that it has entered into a research collaboration agreement with a subsidiary of Merck & Co., Inc. to identify new antibacterial drug candidates.
TradingMarkets
TradingMarkets
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May